The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
This trial is to investigate the efficacy and safety of rotigotine as compared to placebo in
reducing signs and symptoms of fibromyalgia syndrome. The effects of rotigotine on pain,
sleep, general activity, mood, and quality of life, and the use of rescue medication to treat
pain will be assessed.